Our current study demonstrated that resveratrol, as a highly active FASN inhibitor, inhibited both the intracellular FASN activity and FASN expression, and thus induced apoptosis among the three molecular subtypes of breast cancer cell lines. This evidence concerns the gene FASN and breast carcinoma.